% Expired Patents = 16.7

EPO Patents = 2

Forward Citations = 8

Loading Chart...

4 inventors (with patents filed for the assignee):

Antonio Francesco Di Naro (4 out of 12 patents)

Paolo Giuseppe Gobbi Frattini (1 out of 12 patents)

Francesco Tedesco (1 out of 5 patents)

4. Roberto Marzari (1 out of 4 patents)

6 patents: Sort by Forward Citations

1. 12583934 - ANTI-CD26 ANTIBODIES AND USES THEREOF (2026-03-24),

2. 12274671 - Sterile flexible package with pressure compensator for the dosed reconstitution of fluid medicinal or nutritional substances to be administered to patients by infusion or injection (2025-04-14),

3. 11959913 - Quantitative cellular method for determining the biological activity of an anti-CD26 ligand (2024-04-16),

4. 11242399 - Anti-CD26 antibodies (2022-02-08),

5. 9376498 - Anti-CD26 antibodies and uses thereof (2016-06-28),

6. 8962819 - Anti-C5 alpha antibodies (2015-02-24),

Company Overview

Adienne S.a. is a leading biotechnology company focused on the development and commercialization of novel therapies in the fields of oncology and rare diseases. With a strong dedication to innovation and patient care, Adienne S.a. is committed to bringing life-changing treatments to patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#13 in Lugano

#1,587 in Switzerland

Lugano, Switzerland

Adienne S.a.

Forward Citations = 8

4 inventors:

Antonio Francesco Di Naro (4 out of 12 patents)

Paolo Giuseppe Gobbi Frattini (1 out of 12 patents)

Francesco Tedesco (1 out of 5 patents)

4. Roberto Marzari (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Adienne S.a.. Retrieved from https://idiyas.com/company/adienne-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]